Biotech company developing therapeutics that harness the immune system to treat major autoimmune diseases with limited treatment options
Biotech company developing therapeutics that harness the immune system to treat major autoimmune diseases with limited treatment options. Its approach targets signaling between T cells and another important cell type in a biological pathway central to human disease.